Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma: A potential mechanism for high tumor aggressiveness

American Journal of Pathology

Volumn 155, Issue 3, 1999, Pages 753-763

  Kunz, Manfred ^a,c   Hartmann, Anke ^a   Flory, Egbert ^a   Toksoy, Atiye ^a   Koczan, Dirk ^c   Thiesen, Hans Jürgen ^a   Mukaida, Nafoumi ^b   Neumann, Manfred ^a   Rapp, Ulf Rüdiger ^a   Bröcker, Eva Bettina ^a   Gillitzer, Reinhard ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANOXIA; ARTICLE; CANCER IMMUNOLOGY; CANCER INVASION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; MELANOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0032887299     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65174-7     Document Type: Article

References (57)

1. Folkman J, Klagsbrunn M: Angiogenic factors. Science 1987, 235: 442-445
2. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990, 82:4-6
3. Liotta L, Kleinerman J, Saidel G: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastasis following tumor implantation. Cancer Res 1974, 34:997-1004
4. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL: Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 1994, 145:510-514
5. Barnhill RL, Fandrey K, Levy MA, Mihm Jr MC, Hyman B: Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 1992, 67:331-337
6. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ: Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986, 22:1205-1209
7. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988, 133:419-423
8. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H: Biology of tumor progression in human melanocytes. Lab Invest 1987, 56:461-474
9. Bouck N, Stellmach V, Hsu SC: How tumors become angiogenic. Adv Cancer Res 1996, 69:135-174
10. Ladoux A, Frelin C: Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 1993, 195:1005-1010
11. desarg and an anionic neutrophil activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 1986, 87:53-58
12. Walz A, Peveri P, Aschauer AO, Baggiolini M: Purification and amino acid sequencing of NAF, a novel neutrophil activating factor produced by monocytes. Biochem Biophys Res Commun 1987, 149: 755-761
13. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene intercrine cytokine family. Annu Rev Immunol 1991, 9:617-648
14. Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki B: IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993, 151: 2667-2675
15. Scheibenbogen C, Mohler T, Haefele J, Hunstein W, Keilholz U: Serum interleukin-8 is elevated in patients with metastatic melanoma and correlates with tumor load. Melanoma Res 1995, 5:179-181
16. Singh RK, Gutman M, Radinsky R, Bucana CD, Fiedler IJ: Expression of interleukin-8 correlates with metastatic potential of human melanoma cells in nude mice. Cancer Res 1994, 54:3242-3247
17. Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M: Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 1997, 151:1105-1113
18. Wang JM, Taroboletti G, Matsushima K, Damme JV, Mantovani A: Induction of haptotactic migration of melanoma cells by neutrophil activating protein/IL-8. Biochem Biophys Res Commun 1990, 169: 165-170
19. Keane MP, Arenberg DA, Lynch III JP, White RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, Strieter RM: The CXC chemokines: IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997, 159: 1437-1443
20. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 1992, 258:1798-1801
21. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, Elner SG: Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol 1992, 141:1279-1284
22. Gillitzer R, Berger R, Mielke V, Müller C, Wolff K, Stingl G: Upper level keratinocytes of psoriatic lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 1991, 97:73-79
23. Ritter U, Moll H, Laskay T, Bröcker E-B, Velazco O, Becker J, Gillitzer R: Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 1996, 173: 699-709
24. Muijen van GNP, Jansen CFJ, Cornelissen LMHA, Beck JLM, Ruiter DJ: Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer 1991, 48:85-91
25. Lindholm D, Heumann R, Hengerer B, Thoenen H: Interleukin 1 increases stability, and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. J Biol Chem 1988, 263:16348-16351
26. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995, 270:19761-19766
27. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K: Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-κB is a target for glucocorticoid-mediated interleukin-8 gene repression. J Biol Chem 1994, 269:13289-13295
28. Hoffmeyer A, Grosse-Wilde A, Flory E, Neufeld B, Kunz M, Rapp UR, Ludwig S: Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor α gene expression in T lymphocytes. J Biol Chem 1999, 274:4319-4327
29. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription regulation initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11:1475-1489
30. Lee LF, Haskill S, Mukaida N, Matsushima K, Ting JPY. Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter. Mol Cell Biol 1997, 17:5097-5105
31. Mukaida N, Mahe Y, Matsushima K: Cooperative interaction of nuclear factor-κB-and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by proinflammatory cytokines. J Biol Chem 1990, 265:21128-21133
32. Murayama T, Ohara Y, Obuchi M, Khabar KSA, Higashi H, Mukaida N, Matsushima K: Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1 and NF-κB-binding sites of the interleukin-8 gene. J Virol 1997, 71:5692-5695
33. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K: Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J Biol Chem 1992, 267:22506-22511
34. Gutman M, Singh RK, Xie K, Bucana CD, Fiedler IJ: Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res 1995, 55:2470-2475
35. Desbaillets I, Diserens AC, de Tribolet N, Hamou MF, van Meir EG: Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 1997, 8:1201-1212
36. Desbaillets I, Diserens AC, de Tribolet N, Hamou MF, van Meir EG: Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 1999, 18:1447-1456
37. Stein I, Neeman M, Shweiki D, Hin H, Keshet E: Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 1995, 15:5363-5368
38. Levy AP, Levy NS, Goldberg MA: Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996, 271:2746-2753
39. Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S: Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB, and CCAAT/ enhancer-binding protein-like cis-elements. J Biol Chem 1991, 266: 13759-13763
40. Rupec RA, Baeuerle PA: The genomic response of tumor cells to hypoxia and reoxygenation: differential activation of transcription factors AP-1 and NF-κB. Eur J Biochem 1995, 234:632-640
41. Bandyopadhyay RS, Phelan M, Faller DV: Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim Biophys Acta 1995, 1264: 72-78
42. Mukaida N, Shiroo M, Matsushima K: Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989, 143:1366-1371
43. Semenza GL, Jiang BH, Leung SW, Passatino R, Concordet JP, Maire P, Giallongo A: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sides for hypoxia-inducible factor 1. J Biol Chem 1996, 271:32529-32537
44. Damert A, Ikeda E, Risau W: Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J 1997, 327:419-423
45. Wenger RH, Gassmann M: Little difference. Nature 1996, 380:100
46. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997, 3:177-182
47. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995, 270:16483-16486
48. Karin M, Zheng-gang L, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol 1997, 9:240-246
49. Young SD, Marshall RS, Hill RP: Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 1993, 85:9533-9537
50. Norrby K: Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif 1996, 29:315-323
51. Yoshida S, Mayumi O, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M: Involvement of Interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis. Mol Cell Biol 1997, 17:4015-4023
52. Petzelbauer P: IL-8 and angiogenesis. Evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995, 7:267-272
53. Norgauer J, Metzner B, Schraufstetter I: Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J Immunol 1996, 156:1132-1137
54. Bordoni R, Fine R, Murray D, Richmond A: Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J Cell Biochem 1990, 44:207-219
55. Jones SA, Moser B, Thelen M: A comparison of post-receptor signal transduction events in Jurkat cells transfected with either IL-8R1 or IL-8R2: chemokine mediated activation of p42/p44 MAP-kinase (ERK-2). FEBS Lett 1995, 364:211-214
56. Robinson MJ, Copp MH: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997, 9:180-186
57. Horuk R: The interleukin-8 receptor family: from chemokines to malaria. Immunol Today 1994, 15:169-174